Katharine Schulz, Ph.D., is a patent agent in the Intellectual Property Group. She assists the attorney team and intellectual property clients in the preparation and prosecution of patent applications with a focus on life sciences.
Katharine works on a wide array of technologies, including:
- Therapeutics, such as vaccines, antibodies, protein therapeutics, probiotics, nutraceuticals, and gene therapies
- Diagnostic assays and biomarkers
- Stem cells and cell culture
- Genetically engineered plants, animals and microorganisms
- Plant patents and crop improvement
Katharine's core technical experience is in the fields of biochemistry and molecular biology. She has more than 8 years of experience as a research scientist and has authored scientific research and review papers. As an undergraduate, she studied the teratogenic effects of retinoids on the developing mouse fetus, and as a graduate student, she studied chromatin remodeling in the developing Drosophila embryo.
As an undergraduate, she completed two industry internships in food safety and software testing. While pursuing her graduate degree, she served as a student ambassador for the University's Technology Transfer Office and as a teaching assistant for two undergraduate biochemistry courses. She also assisted with a project for the University of Wisconsin Law & Entrepreneurship Clinic and gave public lectures on the topics of CRISPR-based genome editing and model organisms at science outreach events.
Education and Honors
- University of Wisconsin - Madison (Ph.D., 2018)
- Doctor of Philosophy, Integrated Program in Biochemistry
- Thesis title: Defining the interaction of Zelda with chromatin
- NIH Molecular Biosciences Training Grant Recipient
- Genetics Society of America Poster Award, 56th Annual Drosophila Research Conference
- University of Wisconsin - Madison (B.S., with distinction, 2012)
- Major: Biochemistry
- Senior thesis title: Assessing the teratogenicity of synthetic retinoids in mice
- Phi Kappa Phi
- National Society of Collegiate Scholars